FTO‐04 has an inhibitory effect on glioblastoma, blocking neurosphere formation and self‐renewal capabilities of GSCs and therefore demonstrating its potential to overcome chemoresistance.[141] The enantiomer of 2‐hydroxyglutarate (R‐2HG), an oncometabolite, also has FTO inhibitory properties. Here, FTO is linked to glioblastoma.